|Bid||1.2400 x 1400|
|Ask||1.2500 x 900|
|Day's Range||1.2100 - 1.2500|
|52 Week Range||0.8000 - 2.2800|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 03, 2023 - May 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.00|
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript March 3, 2023 Operator: Welcome to Oncolytics Biotech’s Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Jon Patton, Director of Investor Relations and […]
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the fourth quarter and full year ended December 31, 2022. All dollar amounts are expressed in Canadian currency unless otherwise noted.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, March 3, 2023, at 8:30 a.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2022.